-
Je něco špatně v tomto záznamu ?
Longitudinal course of core cognitive domains in first-episode acute and transient psychotic disorders compared with schizophrenia
K. Knížková, B. Keřková, M. Večeřová, P. Šustová, J. Jonáš, A. Siroňová, A. Hrubý, M. Rodriguez
Status neindexováno Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2014
Free Medical Journals
od 2014
PubMed Central
od 2014
Open Access Digital Library
od 2014-03-01
Elsevier Open Access Journals
od 2014-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2014
- Publikační typ
- časopisecké články MeSH
Acute and transient psychotic disorder (ATPD) is characterized by acute onset of psychotic symptoms and early recovery. Contrastingly, schizophrenia (SZ) is a chronic mental disorder characterized by impaired functioning including a deficit in cognition. In SZ, the cognitive deficit is among the core symptoms, but in ATPDs, the existing evidence brings mixed results. Our primary aim was to compare three core cognitive domains (executive functioning/abstraction, speed of processing and working memory) of patients diagnosed with ATPD and SZ over a 12-month period. Moreover, we explored how these diagnostic subgroups differed in their clinical characteristics. We recruited 39 patients with a diagnosis of SZ and 31 with ATPD with schizophrenic symptoms. All patients completed clinical and neuropsychological assessments. At baseline, we used a one-way ANCOVA model with a group as the between-subjects factor. Mixed-model repeated-measures ANOVAs with time as the within-subjects factor and group as the between-subjects factor were run to test the overtime differences. At baseline, we did not find any differences in cognition - with sex, education and age as covariates - between ATPDs and SZ. After one year, all patients showed an improvement in all three domains, however, there were no significant overtime changes between ATPDs and SZ. Regarding clinical profiles, ATPDs demonstrated less severe psychopathology and better functioning compared to SZ both at baseline and after 12 months. The medication dosage differed at retest, but not at baseline between the groups. Our findings suggest clinical differences and a similar trajectory of cognitive performance between these diagnostic subgroups.
Department of Psychology Faculty of Arts Charles University Prague Czech Republic
Department of Psychology Faculty of Social Studies Masaryk University Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24012443
- 003
- CZ-PrNML
- 005
- 20240726151355.0
- 007
- ta
- 008
- 240723e20240405xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.scog.2024.100311 $2 doi
- 035 __
- $a (PubMed)38601889
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Knížková, Karolína $u National Institute of Mental Health, Klecany, Czech Republic $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
- 245 10
- $a Longitudinal course of core cognitive domains in first-episode acute and transient psychotic disorders compared with schizophrenia / $c K. Knížková, B. Keřková, M. Večeřová, P. Šustová, J. Jonáš, A. Siroňová, A. Hrubý, M. Rodriguez
- 520 9_
- $a Acute and transient psychotic disorder (ATPD) is characterized by acute onset of psychotic symptoms and early recovery. Contrastingly, schizophrenia (SZ) is a chronic mental disorder characterized by impaired functioning including a deficit in cognition. In SZ, the cognitive deficit is among the core symptoms, but in ATPDs, the existing evidence brings mixed results. Our primary aim was to compare three core cognitive domains (executive functioning/abstraction, speed of processing and working memory) of patients diagnosed with ATPD and SZ over a 12-month period. Moreover, we explored how these diagnostic subgroups differed in their clinical characteristics. We recruited 39 patients with a diagnosis of SZ and 31 with ATPD with schizophrenic symptoms. All patients completed clinical and neuropsychological assessments. At baseline, we used a one-way ANCOVA model with a group as the between-subjects factor. Mixed-model repeated-measures ANOVAs with time as the within-subjects factor and group as the between-subjects factor were run to test the overtime differences. At baseline, we did not find any differences in cognition - with sex, education and age as covariates - between ATPDs and SZ. After one year, all patients showed an improvement in all three domains, however, there were no significant overtime changes between ATPDs and SZ. Regarding clinical profiles, ATPDs demonstrated less severe psychopathology and better functioning compared to SZ both at baseline and after 12 months. The medication dosage differed at retest, but not at baseline between the groups. Our findings suggest clinical differences and a similar trajectory of cognitive performance between these diagnostic subgroups.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Keřková, Barbora $u National Institute of Mental Health, Klecany, Czech Republic
- 700 1_
- $a Večeřová, Monika $u National Institute of Mental Health, Klecany, Czech Republic
- 700 1_
- $a Šustová, Petra $u National Institute of Mental Health, Klecany, Czech Republic $u Department of Psychology, Faculty of Arts, Charles University in Prague, Czech Republic
- 700 1_
- $a Jonáš, Juraj $u National Institute of Mental Health, Klecany, Czech Republic $u Department of Psychology, Faculty of Arts, Charles University in Prague, Czech Republic
- 700 1_
- $a Siroňová, Aneta $u National Institute of Mental Health, Klecany, Czech Republic $u Department of Psychology, Faculty of Social Studies, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Hrubý, Aleš $u National Institute of Mental Health, Klecany, Czech Republic
- 700 1_
- $a Rodriguez, Mabel $u National Institute of Mental Health, Klecany, Czech Republic
- 773 0_
- $w MED00215025 $t Schizophrenia research. Cognition $x 2215-0013 $g Roč. 37 (20240405), s. 100311
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38601889 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240723 $b ABA008
- 991 __
- $a 20240726151348 $b ABA008
- 999 __
- $a ok $b bmc $g 2125386 $s 1224306
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 37 $c - $d 100311 $e 20240405 $i 2215-0013 $m Schizophrenia research. Cognition $n Schizophr Res Cogn $x MED00215025
- LZP __
- $a Pubmed-20240723